Vivani Medical Inc (VANI) NPV
Sell:$1.03Buy:$1.10
$0.03
(2.86%)
- This stock can be held in a
Stocks and Shares ISA$0.03
(2.86%)$0.03
(2.86%)Company Information
About this company
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
Key people
Key facts
- EPICVANI
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS92854B1098
- Market cap$65.75m
- Employees44
- Shares in issue59.23m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.